Ozempic , Mounjaro , and Wegovy are now firmly in the TOP10, with Zepbound on track to join soon
Study Design In the present study, researchers evaluated the association between GLP-1 agonist use and breast cancer incidence
Metformin comes with a black box warning for lactic acidosis, a condition in which acid builds up in the body
Don't let the needle touch anything once the cap is off
Rachel Sorvig, a spokesperson for Zepbound and Mounjaro manufacturer Eli Lilly, said in a statement that users should "talk to their health care provider about dosage and duration needs." Studies have shown that people typically regain a substantial amount of weight within a year of stopping GLP-1 medications, and that many people who quit ultimately go back on the drugs
Chou CC, Pan SY, Sheen YJ, et al